{"schema_version":"secwatch.filing_event.v1","accession":"0000927653-22-000095","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2022-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.080480+00:00","generated_at":"2026-06-22T21:05:00.223182+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"McKesson Q2 revenue $70.2B (+5%), EPS $6.46 vs $1.71; raises FY23 adj. EPS guidance to $24.45-24.95","bullets":["Total revenues of $70.2B increased 5% YoY; income from continuing operations $932M vs $267M.","GAAP EPS $6.46 (up $4.75); adjusted EPS $6.06 (down 1%), up 11% excluding COVID-related items.","Raised FY2023 adjusted EPS guidance to $24.45-24.95 (prior $23.95-24.65), 11-14% growth vs prior year.","COVID-19 vaccine distribution and ancillary programs contributed ~$1.60-1.80 to adjusted EPS guidance.","Year-to-date adjusted EPS $11.89 (+2% YoY); U.S. government COVID programs remain a key driver."],"urls":{"canonical":"https://secwatch.observer/filing/0000927653-22-000095","json":"https://secwatch.observer/filing/0000927653-22-000095.json","markdown":"https://secwatch.observer/filing/0000927653-22-000095.md","text":"https://secwatch.observer/filing/0000927653-22-000095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000092765322000095/0000927653-22-000095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000092765322000095/mck-20221101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T21:05:00.223182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}